Next-generation sequencing (NGS) has opened up novel diagnostic opportunities for children with unidentified, but suspected inherited diseases. We describe our single-center experience with NGS diagnostics in standard clinical scenarios in pediatric hepatology. We investigated 135 children with suspected inherited hepatopathies, where initially no causative pathogenic variant had been identified, with an amplicon-based NGS panel of 21 genes associated with acute and chronic hepatopathies. In 23 of these patients, we detected pathogenic or likely pathogenic variants in 10 different genes. We present 6 novel variants. A total of 14 of these patients presented with the characteristic phenotype of the related hepatopathy. Nine patients showed only few or atypical clinical symptoms or presented with additional signs. In another 13 out of 135 cases, we detected variants of unknown significance (VUS) in 9 different genes.
| INTRODUCTION
Children presenting with liver disease often have an underlying genetically determined disorder. The majority of cases belong to the rare diseases and, frequently, there is a delay in establishing a diagnosis, which relies on typical clinical phenotypes supported by conventional laboratory or radiological analysis. Pediatric cholestatic diseases often present with overlapping phenotypes making accurate diagnosis challenging. The underlying conditions for the clinical phenotype "neonatal cholestasis" encompass infection, immaturity and biliary atresia as well as numerous orphan diseases. 1 The most frequent are the entity of progressive familial intrahepatic cholestasis, a heterogeneous group of bile acid transporter defects and related conditions 
| MATERIALS AND METHODS
Details are provided in Appendix S1 (Supporting information).
| Patients
We analyzed DNA samples from 135 patients with suspected heredi- 
| Data analysis
Read alignment to the human reference genome (hg19, Genome Ref- c Patient has also heterozygous frequent variant c.1772A>G, p.(Asn591Ser) in ABCB11 (highest observed allele frequency: 11.22% in South Asian population, average allele frequency: 1.58%, Exome Aggregation Consortium) described in association with intrahepatic cholestasis of pregnancy. 
| Patients with VUS
We also detected VUS that were mostly atypical albeit still compatible with the phenotype (Table 2, Table S2 ). In the following, we discuss the most interesting cases with strongest indication for pathogenicity.
1. Seven-year-old patient LP147 showed a severe hepatopathy of undefined etiology, impaired growth and celiac disease. We detected the homozygous variant c.293C>T, p.(Pro98Leu) in MPV17, (Table 2) . Pathogenic MPV17 variants are associated with Navajo neurohepatopathy, a severe infantile hepatocerebral MTDPS, often leading to death in the first year of life c Patient has also heterozygous frequent variant c.523A>G, p.(Thr175Ala) in ABCB4 (highest observed allele frequency: 3.38% in Finnish Population, average allele frequency: 1.06%, Exome Aggregation Consortium). Variant is known to be associated with intrahepatic cholestasis of pregnancy, low phospholipid-associated cholelithiasis syndrome and has been found in compound heterozygous state in a patient with progressive familial intrahepatic cholestasis. 5 However, variant is without effect of localization or function of ABCB4 protein in in vitro assays 5 and has been found in homozygous state in 11 controls (Exome Aggregation Consortium).
(OMIM#256810). However, the homozygous MPV17 variant c.293C>T has been described in patients with adult onset of neurohepatopathy and leukoencephalopathy. 6 Patient LP147 showed only mild myopathy and exhibited no psychiatric or neurological symptoms until now, emphasizing the wide spectrum of phenotypical presentations in mitochondriopathies. 3. In patients LP112 and LP132 we found the same NOTCH2 variant c.6094C>A, p.(His2032Asn) ( Table 2) . This rare variant is located in the highly conserved sixth Ankyrin repeat of NOTCH2
and is predicted to be pathogenic (Table S2) 
| Outlook
In 73% of the patients of our population, we found no or-in case of recessive inheritance-only a heterozygous pathogenic variant or VUS. Also in these 73% of patients, we identified several VUS completely incompatible with the phenotype. 
